Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: A randomized, placebo- controlled, double-blind, multicenter trial

Clinical Infectious Diseases

Volumn 28, Issue 2, 1999, Pages 250-255

  Menichetti, Francesco ^{a,b,c,d,e,f,g}   Del Favero, Albano ^a,b,c,d,e,f   Martino, Piero ^a,b,c,d,e,f   Bucaneve, Giampaolo ^a,b,c,d,e,f   Micozzi, Alessandra ^a,b,c,d,e,f   Girmenia, Corrado ^a,b,c,d,e,f   Barbabietola, Giuliana ^a,b,c,d,e,f   Pagano, Livio ^a,b,c,d,e,f   Leoni, Pietro ^a,b,c,d,e,f   Specchia, Giorgina ^a,b,c,d,e,f   Caiozzo, Alessandro ^a,b,c,d,e,f   Raimondi, Roberto ^a,b,c,d,e,f   Mandelli, Franco ^a,b,c,d,e,f   Cascavilla, N ^v   Rigolin, G ^h   Deliliers, G Lambertenghi ⁱ   Martino, B ^v   Peta, A ^j   Ricci P , ^v   Fanci, R ^k   De Plano, W ^l   Sivera, P ^m   Zagonel, V ⁿ   Caramatti, C ^v   Invernizzi, R ^o   Buelli, M ^v   Bernasconi, C ^o   Carella, A ^p   Damasio, E ^v   De Biasi, R ^q   Chierichini, A ^v   Galieni, P ^r   Grasso, M ^v   Jacopino, P ^v   Morra, E ^s   Porcellini, A ^v   Resegotti, L ^v   Ricciuti, F ^v   Picardi, M ^t   Ronconi, F ^v   Cimino, R ^u,v   Ferrandina, C ^v   Gabbas, A ^v   Mettivier, V ^u   more..

^a UNIVERSITY OF PERUGIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d UNIVERSITY OF BARI   (Italy)

^e UNIVERSITY OF PALERMO   (Italy)

^f SAN BORTOLO HOSPITAL   (Italy)

^g POLICLINICO MONTELUCE   (Italy)

^h UNIVERSITY HOSPITAL OF FERRARA   (Italy)

ⁱ FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^j PUGLIESE CIACCIO HOSPITAL   (Italy)

^k CAREGGI UNIVERSITY HOSPITAL   (Italy)

^l Ospedale Oncologico A Businco   (Italy)

^m SAN LUIGI GONZAGA HOSPITAL   (Italy)

ⁿ CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^o FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^p UNIVERSITY OF GENOA   (Italy)

^q Ospedale Nuovo Cardarelli   (Italy)

^r Ospedale A Sclavo   (Italy)

^s OSPEDALE NIGUARDA CA GRANDA   (Italy)

^t Nuovo Policlinico   (Italy)

^u CARDARELLI HOSPITAL   (Italy)

^v Ematologia Ospedale Cardarelli ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MYCOSIS; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0033047475     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515129     Document Type: Article

References (18)

1. 1. Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992;326:845-51.
2. 2. Slavin MA, Osborne B, Adams R, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a prospective, randomized, double-blind study. J Infect Dis 1995;171:1545-52.
3. 3. Winston DJ, Chandrasekar PH, Lazarus HM, et al. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized, placebo-controlled, double-blind, multicenter trial. Ann Intern Med 1993;118:495-503.
4. 4. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991;325:1274-7.
5. 5. Vreugdenhil G, van Dijke BJ, Donnely P, et al. Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study. Leuk Lymphoma 1994;11:353-8.
6. 6. Tricot G, Joosten E, Boogaerts MA, Vande Pitte J, Cauwenbergh G. Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. Rev Infect Dis 1987;9(suppl 1):S94-9.
7. 7. Wilcox CM, Darouiche RO, Laine L, Moskovitz BL, Mallegol I, Wu J. A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis. J Infect Dis 1997;176:227-32.
8. 8. Prentice AG, Warnock DW, Johnson SAN, Phillips MJ, Oliver DA. Multiple dose pharmacokinetics of an oral solution of itraconazole in autologus bone marrow transplant recipients. J Antimicrob Chemother 1994;34:247-52.
9. 9. Prentice AG, Warnock DW, Johnson SAN, Taylor PC, Oliver DA. Multiple dose pharmacokinetics of an oral solution of itraconazole in patients receiving chemotherapy for acute myeloid leukemia. J Antimicrob Chemother 1995;36:657-63.
10. 10. Morgenstern GR, Prentice AG, Prentice HG, Ropner JE, Schey SA, Warnock DW. Itraconazole oral solution vs. fluconazole suspension for antifungal prophylaxis in neutropenic patients [abstract LM34]. In: Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans). Washington, DC: American Society for Microbiology, 1996:286.
11. 11. GIMEMA ALL 0183: a multicentric study on adult acute lymphoblastic leukemia. The 1990 update [abstract 1248]. Blood 1990;76(suppl 1): 314.
12. 12. EORTC/GIMEMA. Allogenic versus autologous BMT versus intensive consolidation in acute myelogenous leukemia in first remission. An EORTC/GIMEMA phase III trial (LAM 8 A) [abstract 1349]. Blood 1990;76(suppl 1):340.
13. 13. The Gimema Infection Program. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized multicenter trial comparing norfloxacin with ciprofloxacin. Ann Intern Med 1991;115:7-12.
14. 14. Menichetti F, Del Favero A, Martino P, Gimema Infection Program. Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B. Ann Intern Med 1994;120:913-8.
15. 15. Walsh TJ, Hiemenz J, Pizzo PA. Evolving risk factors for invasive fungal infections - all neutropenic patients are not the same [editorial]. Clin Infect Dis 1994;18:793-8.
16. 16. Gøtzche PC, Johansen HK. Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia. Br Med J 1997;314:1238-44.
17. 17. Schaffner A, Schaffner M. Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias. J Infect Dis 1995;172:1035-41.
18. 18. Palmblad J, Lonnqvist B, Carlsson B, et al. Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukemia in adults: more bacteremias. J Intern Med 1992;231:363-70.